[go: up one dir, main page]

DE1139236B - Process for the production of therapeutically valuable stitosterol preparations - Google Patents

Process for the production of therapeutically valuable stitosterol preparations

Info

Publication number
DE1139236B
DE1139236B DEB65853A DEB0065853A DE1139236B DE 1139236 B DE1139236 B DE 1139236B DE B65853 A DEB65853 A DE B65853A DE B0065853 A DEB0065853 A DE B0065853A DE 1139236 B DE1139236 B DE 1139236B
Authority
DE
Germany
Prior art keywords
sitosterol
preparations
production
therapeutically valuable
stitosterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEB65853A
Other languages
German (de)
Inventor
Dr Peter Rieckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL276700D priority Critical patent/NL276700A/xx
Priority to DEB62020A priority patent/DE1131845B/en
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DEB65853A priority patent/DE1139236B/en
Priority to GB804162A priority patent/GB934686A/en
Priority to LU41386D priority patent/LU41386A1/xx
Priority to BR13716962A priority patent/BR6237169D0/en
Priority to NL276700A priority patent/NL142069B/en
Priority to BE615975A priority patent/BE615975A/en
Publication of DE1139236B publication Critical patent/DE1139236B/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

DEUTSCHESGERMAN

PATENTAMTPATENT OFFICE

B 65853 IVa /30 hB 65853 IVa / 30 h

ANME LDETAG:ANME LDETAG:

BEKANNTMACHUNG DER ANMELDUNG UNDAUSGABE DER AUSLEGESCHRIFT:NOTICE THE REGISTRATION AND ISSUE OF EDITORIAL:

8. FEBRUAR 1962FEBRUARY 8, 1962

8. NOVEMBER 1962NOVEMBER 8, 1962

Gegenstand der Patentanmeldung B 62020 IVa/30h (deutsche Auslegeschrift 1 131 845) ist ein Verfahren zur Herstellung therapeutisch wertvoller Sitosterin-Zubereitungen, welches dadurch gekennzeichnet ist, daß man handelsübliches, grobdispers vorliegendes Sitosterin in Gegenwart ausreichender Mengen von Füllstoffen auf eine Teilchengröße unterhalb 30 Mikron mahlt und das Mahlgut in Anwesenheit von Gelatine in Wasser suspendiert, worauf man aus den so erhaltenen Suspensionen gegebenenfalls das Wasser ganz oder teilweise entfernt.The subject of patent application B 62020 IVa / 30h (German Auslegeschrift 1 131 845) is a method for the production of therapeutically valuable sitosterol preparations, which is characterized by that one commercially available, coarsely present sitosterol in the presence of sufficient amounts of Mills fillers to a particle size below 30 microns and the millbase in the presence of Gelatin suspended in water, whereupon from the suspensions thus obtained, if necessary, the Part or all of the water removed.

Wie in der Hauptpatentanmeldung näher ausgeführt ist, besitzt Sitosterin nur dann eine gute antisklerotische Wirksamkeit, wenn es dem Organismus in sehr feiner Verteilung zugeführt wird. Der Verabreichung von Sitosterin des erforderlichen Zerteilungsgrades stehen jedoch das hohe spezifische Volumen eines solchen Produkts sowie seine außerordentlich starke Hydrophobie im Wege. Weitere Schwierigkeiten ergeben sich beim Vermählen des Handelsproduktes sowie bei der Verdichtung des hohen Volumens, welche (wie ebenfalls in der Hauptpatentanmeldung näher erläutert ist) nur durch Suspendierung in Wasser bewirkt werden kann. Besonders lästig ist die Thixotropie, die wäßrige Suspensionen bzw. Pasten von feinzerteiltem Sitosterin zeigen.As detailed in the main patent application, sitosterol only has a good anti-sclerotic effect Effectiveness when it is supplied to the organism in very fine distribution. The administration of sitosterol of the required degree of division, however, stand the high specific volume of a such a product as well as its extremely strong hydrophobicity in the way. More difficulties arise when grinding the commercial product and when compacting the high volume, which (as is also explained in more detail in the main patent application) only by suspension in Water can be effected. The thixotropy is particularly annoying, the aqueous suspensions or Show pastes of finely divided sitosterol.

Nach dem Verfahren der Hauptpatentanmeldung wird durch Zugabe von Gelatine die Thixotropie der Sitosterin-Suspensionen aufgehoben. Da Gelatine üblicherweise als Verdickungsmittel verwendet wird, war dieser Befund sehr überraschend, zumal es sich herausstellte, daß Alginate und verschiedene Cellulosederivate (Carboxymethylcellulose, Äthylcellulose) keinen solchen Effekt aufweisen. Es wurde nun gefunden, daß man an Stelle von Gelatine auch Methylcellulose zur Aufhebung der Thixotropie von Sitosterin-Suspensionen verwenden kann; Gemische dieser beiden Stoffe sind ebenfalls brauchbar. Die hiermit hergestellten Zubereitungen besitzen im Vergleich zu den nur gelatinehaltigen Präparaten eine erhöhte Stabilität.According to the process of the main patent application, the thixotropy of the Sitosterol suspensions lifted. Since gelatin is commonly used as a thickener, This finding was very surprising, especially since it turned out that alginates and various Cellulose derivatives (carboxymethyl cellulose, ethyl cellulose) do not have such an effect. It was now found that instead of gelatin, methyl cellulose can also be used to neutralize the thixotropy of Can use sitosterol suspensions; Mixtures of these two substances can also be used. the Preparations produced with it have compared to the preparations containing only gelatin increased stability.

Zur Herstellung der neuen Sitosterin-Zubereitungen wird — ebenso wie beim Verfahren der Hauptpatentanmeldung — handelsübliches bzw. sonstwie vorgegebenes grobdisperses Sitosterin in Gegenwart von geeigneten Füllstoffen, z. B. kristallinen Zuckern, wie Rohrzucker oder Milchzucker, in Mahlvorrichtungen ausreichender Zerteilungskraft auf eine Teilchengröße unterhalb 30 Mikron, vorzugsweise etwa 5 bis 10 Mikron, zerkleinert. Hierfür eignen sich besonders gut die sogenannten Strahlmühlen. Dann wird das Mahl-Verfahren zur Herstellung therapeutisch
wertvoller Sitosterin-Zubereitungen
To produce the new sitosterol preparations - as in the process of the main patent application - commercially available or otherwise specified coarsely dispersed sitosterol in the presence of suitable fillers, eg. B. crystalline sugars such as cane sugar or milk sugar, comminuted in grinding devices of sufficient dividing power to a particle size below 30 microns, preferably about 5 to 10 microns. The so-called jet mills are particularly suitable for this. Then the grinding method of preparation becomes therapeutic
valuable sitosterol preparations

Zusatz zur Patentanmeldung B 62020 IVa/30 h
(Auslegeschrift 1 131 845)
Addition to patent application B 62020 IVa / 30 h
(Interpretation document 1 131 845)

Anmelder:Applicant:

C. F. Boehringer & Soehne G. m. b. H.,
Mannheim-Waldhof
CF Boehringer & Soehne G. mb H.,
Mannheim-Waldhof

Dr. Peter Rieckmann, Mannheim-Waldhof,
ist als Erfinder genannt worden
Dr. Peter Rieckmann, Mannheim-Waldhof,
has been named as the inventor

gut — in Abänderung des Verfahrens der Haupt-Patentanmeldung — in Gegenwart von Methylcellulose angeteigt, wobei man (je nach Wassermenge) dünnflüssige Suspensionen bis Pasten erhält, welche keine nennenswerte Thixotropie mehr zeigen. Im allgemeinen genügt ein Zusatz von etwa 0,1 bis 2% Methylcellulose, bezogen auf die eingesetzte Sitosterinmenge. Bei der Anteigung können außerdem etwa gewünschte Geschmackskorrigentien, Konservierungsmittel od. dgl. zugesetzt werden.good - in modification of the procedure of the main patent application - made into a paste in the presence of methylcellulose, whereby (depending on the amount of water) Thin suspensions to pastes are obtained which no longer show any noteworthy thixotropy. In general, an addition of about 0.1 to 2% methyl cellulose, based on the amount used, is sufficient Amount of sitosterol. In addition, any desired flavor corrections and preservatives can be added to the pasting or the like. Be added.

Besonders vorteilhafte Darreichungsformen der erfindungsgemäß herzustellenden Sitosterin-Suspensionen bzw. -Pasten erhält man durch Lyophilisierung derselben.Particularly advantageous forms of administration of the sitosterol suspensions to be produced according to the invention or pastes are obtained by lyophilizing the same.

Beispielexample

40 kg handelsübliches Sitosterin werden (gegebenenfalls nach ausreichender Vorzerkleinerung) mit 10,0 kg kristallinem Rohrzucker gemischt. Die Mischung wird auf einer sogenannten Strahlmühle bis auf eine Teilchengröße von etwa 10 Mikron gemahlen. Das Mahlgut wird mit einer (warm zubereiteten und wieder erkalteten) Lösung aus 0,5 kg Methylcellulose, 12,5 kg Zucker, 100 g Sorbinsäure und 300 g einer l%igen alkoholischen Vanillinlösung in 36,6 kg Wasser zu einer homogenen Masse verrührt.40 kg of commercially available sitosterol are added (if necessary after sufficient pre-shredding) 10.0 kg of crystalline cane sugar mixed. The mixture is made on a so-called jet mill ground to a particle size of about 10 microns. The grist is heated with a (warm prepared and cooled again) solution of 0.5 kg methyl cellulose, 12.5 kg sugar, 100 g sorbic acid and 300 g of a 1% alcoholic vanillin solution in 36.6 kg of water to form a homogeneous mass stirred.

Das erhaltene Produkt kann direkt als »Sitosterin-Saft« verabreicht werden, wobei im Falle der Abfüllung derselben in Flaschen zur Vermeidung einer späteren Verklebung der Flaschenverschlüsse bei der Herstellung des Saftes zweckmäßig etwa 10% der obengenannten Menge Wasser durch Glycerin ersetzt sind.The product obtained can be administered directly as "sitosterol juice", although in the case of bottling same in bottles to avoid later sticking of the bottle closures in the In the preparation of the juice, it is advisable to replace about 10% of the above-mentioned amount of water with glycerine are.

209 680/317209 680/317

Durch Lyophilisiening des Saftes erhält man ein für manche Fälle der therapeutischen Anwendung besonders gut geeignetes »Sitosterin-Granulat«.By lyophilizing the juice one obtains a therapeutic application in some cases particularly suitable »sitosterol granules«.

Claims (1)

PATENTANSPRUCH:PATENT CLAIM: Verfahren zur Herstellung therapeutisch wertvoller Sitosterin-Zubereitungen nach Patentanmeldung B 62020 IVa/30h (deutsche Auslegeschrift 1 131 845), bei dem man handelsübliches, grobdispers vorliegendes Sitosterin in Gegenwart ausreichender Mengen von Füllstoffen auf eine Teilchengröße unterhalb 30 Mikron mahlt und das Mahlgut in Anwesenheit von Gelatine in Wasser suspendiert, worauf man aus den so erhaltenen Suspensionen das Wasser gegebenenfalls ganz oder teilweise entfernt, dadurch gekenn zeichnet, daß man die zum Anteigen des Mahlgutes verwendete Gelatine ganz oder teilweise durch Methylcellulose ersetzt.Process for the production of therapeutically valuable sitosterol preparations according to patent application B 62020 IVa / 30h (German Auslegeschrift 1 131 845), in which one grinds commercially available, coarsely present sitosterol in the presence of sufficient amounts of fillers to a particle size below 30 microns and the millbase in the presence of Suspended gelatin in water, whereupon the water is removed from the suspensions thus obtained, if necessary, in whole or in part, characterized in that the gelatin used to make the ground material is completely or partially replaced by methylcellulose.
DEB65853A 1961-04-05 1962-02-08 Process for the production of therapeutically valuable stitosterol preparations Pending DE1139236B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
NL276700D NL276700A (en) 1961-04-05
DEB62020A DE1131845B (en) 1961-04-05 1961-04-05 Process for the production of therapeutically valuable sitosterol preparations
DEB65853A DE1139236B (en) 1961-04-05 1962-02-08 Process for the production of therapeutically valuable stitosterol preparations
GB804162A GB934686A (en) 1961-04-05 1962-03-01 Therapeutic preparations containing sitosterol
LU41386D LU41386A1 (en) 1961-04-05 1962-03-15
BR13716962A BR6237169D0 (en) 1961-04-05 1962-03-15 IMPROVEMENT IN PROCESS FOR THE PREPARATION OF FINALLY DIVIDED SITOSTERIN COMPOSITIONS
NL276700A NL142069B (en) 1961-04-05 1962-04-03 PROCESS FOR THE PREPARATION OF THERAPEUTICALLY VALUABLE SITOSTEROL PREPARATIONS.
BE615975A BE615975A (en) 1961-04-05 1962-04-04 Therapeutic compositions containing sitosterin and their preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEB62020A DE1131845B (en) 1961-04-05 1961-04-05 Process for the production of therapeutically valuable sitosterol preparations
DEB65853A DE1139236B (en) 1961-04-05 1962-02-08 Process for the production of therapeutically valuable stitosterol preparations

Publications (1)

Publication Number Publication Date
DE1139236B true DE1139236B (en) 1962-11-08

Family

ID=25965908

Family Applications (2)

Application Number Title Priority Date Filing Date
DEB62020A Pending DE1131845B (en) 1961-04-05 1961-04-05 Process for the production of therapeutically valuable sitosterol preparations
DEB65853A Pending DE1139236B (en) 1961-04-05 1962-02-08 Process for the production of therapeutically valuable stitosterol preparations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DEB62020A Pending DE1131845B (en) 1961-04-05 1961-04-05 Process for the production of therapeutically valuable sitosterol preparations

Country Status (6)

Country Link
BE (1) BE615975A (en)
BR (1) BR6237169D0 (en)
DE (2) DE1131845B (en)
GB (1) GB934686A (en)
LU (1) LU41386A1 (en)
NL (2) NL142069B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041612A (en) * 1983-08-13 1985-03-05 Mihama Hisaharu Preventive and remedy for thrombosis
DE3829643A1 (en) * 1988-09-01 1990-03-15 Roecar Holdings Nv PHYTO AND ZOOSTEROLS AND THEIR DERIVATIVES WITH IMPROVED WATER SOLUBILITY
FI105887B (en) * 1996-09-27 2000-10-31 Suomen Sokeri Oy Products containing plant sterol for use in food and therapeutic applications, process for their preparation and their use
FI108110B (en) * 1997-06-13 2001-11-30 Danisco Finland Oy A premixture useful for the food and animal nutrition industry, a process for its preparation and its use
US6423363B1 (en) 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
EP1146798A2 (en) * 1999-01-15 2001-10-24 Nutrahealth Ltd. (UK) Modified food products and beverages, and additives for food and beverages
DE60004479T2 (en) * 1999-02-03 2004-06-24 Forbes Medi-Tech Inc., Vancouver METHOD FOR PRODUCING PHYTOSTEROL OR PHYTOSTANOL MICROPARTICLES
AU2003251484B2 (en) 2002-06-12 2009-06-04 The Coca-Cola Company Beverages containing plant sterols
US7732000B2 (en) 2002-06-20 2010-06-08 General Mills, Inc. Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix
DE102005008445A1 (en) * 2005-02-24 2006-08-31 Cognis Ip Management Gmbh Sugary sterol solid dispersions
US11285108B1 (en) * 2021-03-09 2022-03-29 Naturalis S.A. Phytosterols for the prevention or treatment of non-alcoholic steatohepatitis

Also Published As

Publication number Publication date
DE1131845B (en) 1962-06-20
BE615975A (en) 1962-10-04
NL276700A (en)
BR6237169D0 (en) 1973-05-24
GB934686A (en) 1963-08-21
LU41386A1 (en) 1962-05-15
NL142069B (en) 1974-05-15

Similar Documents

Publication Publication Date Title
EP0126379B1 (en) Two-phase formulation
DE69110592T2 (en) Pharmaceutical preparation with improved taste, containing porous particles, and its method of manufacture.
EP0060933B1 (en) Process for the preparation of a composition for promoting the growth of hair
DE1139236B (en) Process for the production of therapeutically valuable stitosterol preparations
EP0062749A1 (en) Method for the production of precipitated silicas
DE2238540A1 (en) N- (D-6-METHYL-8-ISOERGOLIN-I-YL) -N ', N'-DIAETHYLURA AND ITS SALT AND PRODUCTION OF THE- OR. THE SAME AND THESE PHARMACEUTICAL PRODUCTS, INCLUDING
EP0553658B2 (en) Pharmaceutically active composition from Tanacetum partenium, process of extraction and medicinal composition
EP0343678B1 (en) Process for carefully preparing plant extracts
DE4038385C2 (en) Sitosterol and its glycosides with improved bioavailability
DE2206285A1 (en) TRANSPARENT DENTAL CARE AND DENTAL CLEANING PRODUCTS
DE69207777T2 (en) BODY CARE
DE2623682C3 (en) Process for the preparation of an aqueous dispersion containing sorbic acid as fine particles in a high concentration
DE60013231T2 (en) PROCESS FOR OBTAINING SAFRAN EXTRACTS
DE3526669C2 (en)
DE958243C (en) Process for the production of anhydrous dicalcium phosphate with a cleaning force between 2 and 15, preferably between 10 and 13
DE2750841A1 (en) METHOD OF PREPARING A PROTEIN PREPARATION FROM SAFFLORO SEEDS AND PREPARED PROTEIN PREPARATION
EP0126999B1 (en) Process for making spherical crystalline 5-hydroxytetracycline hydrochloride (oxytetracycline hydrochloride)
DE3523991A1 (en) METHOD FOR PRODUCING AN ELIXIR
DE1543481C (en) Zearalenol derivative and process for its preparation
Jacob et al. Über Bürzeldrüsensekrete von Finkenvögeln: Vergleichende Untersuchung der Bürzellipide vom Grünfink (Carduelis chloris), Gimpel (Pyrrhula pyrrhula) und Hänfling (Carduelis cannabina)/The Uropygial Gland Fats of the Greenfinch, Bullfinch and the Linnet
DE1543481B1 (en) Zearalenol derivative and process for its preparation
DE2405218C3 (en) Antiperspirant product and process for its manufacture
DE948153C (en) Process for the preparation of the higher melting isomer of 2-AEthylcrotonylurea
DE3718661C2 (en) Aqueous methylene bisthiocyanate dispersion
DE702218C (en) Process for the decomposition of wet grains